Form 4: Intuitive Surgical CFO Jamie Samath Executes Stock Transactions Under 10b5-1 Trading Plan

Intuitive Surgical's CFO, Jamie Samath, engaged in multiple stock transactions, including the exercise of stock options and the sale of shares, under a pre-arranged 10b5-1 trading plan.

Summary

• Jamie Samath, CFO of Intuitive Surgical, executed several transactions involving the company's common stock on December 10, 2024.
• These transactions included the acquisition of shares through the exercise of non-qualified stock options and the sale of common stock.
• The transactions were conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1, which expires on May 6, 2025.
• The stock options vest over time, with 12.5% vesting six months after February 10, 2023, and the remainder vesting monthly, and 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter.

Sentiment

Score: 6

Explanation: The document describes routine stock transactions by an executive under a pre-arranged plan, which is neither particularly positive nor negative. The sentiment is neutral to slightly positive due to the use of a 10b5-1 plan.

Positives

• The transactions were conducted under a pre-arranged 10b5-1 trading plan, which is a common practice for executives to avoid accusations of insider trading.
• The vesting schedule of the stock options provides an incentive for the CFO's continued service to the company.

Risks

• The sale of shares by a high-ranking executive could be perceived negatively by some investors, although it is part of a pre-arranged plan.
• The vesting schedule of the stock options is complex and may not be fully understood by all investors.

Future Outlook

The CFO's stock transactions are part of a pre-arranged plan, and future transactions are expected to occur under the same plan until its expiration on May 6, 2025.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies, and the use of 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the medical device industry such as Medtronic and Stryker.
• The vesting schedules for stock options are also typical, designed to align executive compensation with long-term company performance, similar to practices at other large cap companies.

Stakeholder Impact

• The stock transactions may have a minor impact on shareholders, but the use of a 10b5-1 plan mitigates concerns about insider trading.
• The vesting schedule of the stock options is designed to align the CFO's interests with the long-term success of the company, which is beneficial for all stakeholders.

Next Steps

• The CFO may continue to execute stock transactions under the 10b5-1 trading plan until its expiration on May 6, 2025.

Key Dates

Keywords

Intuitive Surgical, ISRG, Jamie Samath, Stock Transactions, 10b5-1 Trading Plan, Stock Options, Vesting, SEC Rule 10b5-1, CFO